Health News (Reuters)

Study shows downside of medical crowdfunding

(Reuters Health) - While crowdfunding platforms can fill insurance gaps, helping patients pay for essential care and avoid medical debt, they are also being used to raise large sums of money for ineffective and experimental treatments, a new study suggests.

Don't give decongestants to children for colds, experts say

(Reuters Health) - For children under age 12, decongestants might ease the common cold symptoms of a blocked or running nose, but these medications may not be safe for this age group, according to a research review.

AbbVie rheumatoid arthritis drug succeeds in late stage trial

AbbVie Inc on Tuesday said its experimental rheumatoid arthritis (RA) treatment showed significant improvement in physical function, pain and quality of life compared with the commonly prescribed generic drug methotrexate in a late stage clinical trial.

AstraZeneca digs deeper into cancer with Innate stake

AstraZeneca is plowing deeper into cancer immunotherapy through a wide-ranging deal with Innate Pharma, which includes the British group buying a 9.8 percent stake in the French biotech company.

JUUL's social media campaign resonates alarmingly with teens

(Reuters Health) - The popular e-cigarette brand JUUL is attracting an alarming number of teens online, researchers say. At least a quarter of JUUL's twitter followers may be under 18, they write in the Journal of Adolescent Health.

U.S. farmers, government fight risk of African swine fever

U.S. hog farmers are ramping up safety procedures and leaving animal-feed ingredients imported from China in storage in an attempt to keep out a highly contagious swine disease that is sweeping through Asia and Europe.

Pages